SAN FRANCISCO, Calif. (TheStreet) — Medivation(MDVN Quote) CEO David Hung has delivered another drug partnership, this time for the company’s prostate cancer drug MDV-3100.
Japanese drug maker Astellas said Tuesday that it will pay an upfront fee of $110 million in cash to Medivation in exchange for worldwide marketing rights to MDV-3100, which recently began a pivotal phase III study.
Medivation is also eligible to receive from Astellas another $335 million in cash milestone payments tied to MDV-3100 meeting future development and regulatory goals, plus an added $320 million in commercial milestone payments.
Astellas and Medivation will jointly market MDV-3100 in the U.S. and share costs and profits equally. Astellas will sell the drug outside the U.S. and pay Medivation a double-digit royalty based on sales. A phase III study of MDV-3100 enrolled its first prostate cancer patient on Sept. 23. The study compares MDV-3100 againt a placebo in 1,200 patients with advanced prostate cancer who have already received first-line treatment with the chemotherapy drug Taxotere. The primary goal of the study is to demonstrate that MDV-3100 can prolong survival in these patients.
In September 2008, Medivation’s Hung negotiated one of the biggest partnership deals of that year when Pfizer(PFE Quote) bought worldwide commercial rights to Dimebon, Medivation’s Alzheimer’s drug.
More recently, Johnson & Johnson(JNJ Quote) paid roughly $900 million in May to acquire Cougar Biotechnology, which is developing a prostate cancer drug very similar to Medivation’s MDV-3100.
Medivation shares closed Monday at $26.10.
– Reported by Adam Feuerstein in Boston
http://www.thestreet.com/story/10617222/1/medivation-lands-partner-for-prostate-cancer-drug.html?cm_ven=GOOGLEFI
http://www.dimebonalzheimers.com
Related Websites - Farmers Market Produce (part 2 of a series) We are told to eat a rainbow of different fruits and vegetables, but nobody really ever explains why. Why is it so vitally important for us to eat fruits and...
- Dr. Vipul Patel at Celebration Health Dr. Vipul Patel: A World Renowned Robotic Prostate Cancer Surgeon Robotic Prostatectomy is gaining more and more popularity over conventional surgery. With traditional surgery, the incision is between eight to ten...
- 6 Cancer-Fighting Super Foods in 1 Meal Cancer is still one of the leading causes of death in the United States and every year, thousands more are affected by some form of the disease. While the jury...
- Why You're Wrong If You Think Gold at $2000/oz Is Unlikely... or Worse, Just a Bubble A gold tsunami is at our doorstep. It's not about a bubble, trade or even a wall of fear. It might be partly some of each of those things, but...
- Nanotech Robots Developed to Fight Cancer [/caption] On Sunday, March 21, 2010, a group of United States researchers released their findings in the journal Nature. The study offers early proof that a new treatment approach of...
- Daily supplements for the aging While you should consult with a physician before undertaking radical changes to your diet or vitamin and supplement intake, we've listed here a few supplements that have become staples on...
- Bisphenol-A poses major health risks We first wrote about bisphenol-A (BPA) about two years ago. In that article, we noted that while parents were shying away from plastic baby bottles containing the substance, they were...